# Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-05 17:29 UTC · Category: Business · Sources: 2 · Current Velocity: 0.71

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioPharma Dive | Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines | 2026-09-05 01:18 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxQeERnY3JuVDRwWVFwRmNQQkNPWW15Zm5lWlZEdVVBRmVMMmdyLXpmcjFsOW44XzBjVFVWdEtDWjE3Vm9rMDZGMVZIMzVRYUIxZFQtek56MnItcjFwZjFjQVZCcWZsWmZUUno2NnA5Y0lXOVZ3eGYwb2k4bDBhR1lMSjBoaTEyWVVURzFDXzQwQVgxS2JOalFhOHdfemFxZjh0?oc=5) |
| Barron's | A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares? | 2026-09-05 01:18 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPSHdPbnQtYmYzMFlLWHVBb2Z5cWlqRFQ1MllUbFA4T2V3a3hCVWpCeGZHdC1PYm9uamIwT2lXOGpKTGFKbU1waVFUVjAwX3hKb3NFbHNWOVpPdGVWTkplOUxMb09QOFdlUXpOaDNDdEo0dUZWRE9VMUVRTWdTSmhQR0c5TUN5UzZUclVMdExrSW54N1lv?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-05/novartis-lp-a-drug-fails-to-lower-cardiovascular-risk-in-closely-watched-ph-3*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*